Diurnal cortisol trajectories from mid-pregnancy to one year after birth

Bonnie van Kessel1, Gabrielle R Rinne2, Michele L Okun3

  • 1Centre for Social Sciences, Athabasca University, Athabasca, AB, Canada.

Psychoneuroendocrinology
|November 12, 2025
PubMed

Insights

Diurnal cortisol patterns, including cortisol awakening response (CAR) and area under the curve (AUCg), showed changes during pregnancy and the postpartum period. Maternal ethnicity and gestational length influenced these HPA axis trajectories.

Area of Science:

  • Endocrinology
  • Perinatal Health
  • Stress Physiology

Background:

  • The hypothalamic-pituitary-adrenal (HPA) axis regulates pregnancy and postpartum recovery.
  • Diurnal cortisol indices like CAR, AUCg, and slope assess HPA axis activity.
  • Within-person changes in these indices during the perinatal period and associated factors are unclear.

Purpose of the Study:

  • To investigate within-person changes in diurnal cortisol indices (CAR, AUCg, slope) from mid-pregnancy to one year postpartum.
  • To examine how sociodemographic, pregnancy, and health factors moderate these changes.

Main Methods:

  • 172 pregnant women provided saliva samples at six perinatal time points.
  • Cortisol levels were measured, and CAR, AUCg, and slope indices were calculated.
  • Piecewise growth curve models analyzed within-person changes and moderating factors.

Main Results:

  • Area under the curve (AUCg) increased from mid-to-late pregnancy (linear and quadratic effects observed).
  • No significant within-person changes in CAR or slope were found during pregnancy or postpartum.
  • Hispanic ethnicity was linked to increasing CAR postpartum, while longer gestation correlated with increasing AUCg postpartum.

Conclusions:

  • AUCg demonstrated an increase from mid-to-late pregnancy.
  • Maternal ethnicity and gestational length were identified as moderators of diurnal cortisol trajectories specifically in the postpartum period.
Abstract

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.4K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
338